Position in JNJ
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$21,370,813
+$974,740 QoQ
Shares Held
84,147
+0.8% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
2.87%
of 13F equity value
Holder Rank
#715
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Koshinski Asset Management, Inc. holds $47,150,309 across 10 Drug Manufacturers - General names. JNJ ranks #1 (45.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
84,147 | $21,370,813 | |
| 2 | ABBV |
AbbVie Inc.
|
34,655 | $8,720,584 | |
| 3 | LLY |
ELI LILLY & Co
|
5,099 | $6,115,894 | |
| 4 | PFE |
Pfizer Inc
|
146,261 | $3,521,964 | |
| 5 | AMGN |
Amgen Inc
|
9,577 | $3,468,023 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
21,669 | $1,248,567 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
7,983 | $1,008,572 | |
| 8 | AZN |
Astrazeneca PLC
|
4,741 | $898,988 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $21,370,813 | 84,147 | Shares | Sole | 2026-07-27 | |
| 2026-03-31 | $20,396,073 | 83,440 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $17,421,257 | 84,181 | Shares | Sole | 2026-02-03 | |
| 2025-09-30 | $16,271,532 | 87,755 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $12,866,132 | 84,230 | Shares | Sole | 2025-07-29 | |
| 2025-03-31 | $7,628,640 | 46,000 | Shares | Sole | 2025-04-25 | |
| 2024-12-31 | $6,516,143 | 45,057 | Shares | Sole | 2025-01-16 | |
| 2024-09-30 | $7,532,062 | 46,477 | Shares | Sole | 2024-10-10 | |
| 2024-06-30 | $6,803,309 | 46,547 | Shares | Sole | 2024-07-12 | |
| 2024-03-31 | $5,825,979 | 36,829 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $4,391,383 | 28,017 | Shares | Sole | 2024-01-29 | |
| 2023-09-30 | $7,467,901 | 47,948 | Shares | Sole | 2023-10-18 | |
| 2023-06-30 | $7,906,393 | 47,767 | Shares | Sole | 2023-07-28 | |
| 2023-03-31 | $8,623,270 | 55,634 | Shares | Sole | 2023-04-12 | |
| 2022-12-31 | $9,881,801 | 55,940 | Shares | Sole | 2023-01-24 | |
| 2022-09-30 | $9,195,697 | 56,291 | Shares | Sole | 2022-10-20 | |
| 2022-06-30 | $9,880,916 | 55,664 | Shares | Sole | 2022-07-12 | |
| 2022-03-31 | $8,029,759 | 45,307 | Shares | Sole | 2022-04-20 | |
| 2021-12-31 | $8,195,963 | 47,910 | Shares | Sole | 2022-01-14 | |
| 2021-09-30 | $7,600,513 | 47,062 | Shares | Sole | 2021-10-12 | |
| 2021-06-30 | $6,238,209 | 37,867 | Shares | Sole | 2021-07-26 | |
| 2021-03-31 | $7,728,230 | 47,023 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $6,387,267 | 40,585 | Shares | Sole | 2021-03-30 | |
| 2020-09-30 | $5,831,778 | 39,171 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $5,406,801 | 38,447 | Shares | Sole | 2020-07-29 | |
| 2020-03-31 | $4,961,172 | 37,834 | Shares | Sole | 2020-04-30 | |
| No filing history on record for this holder in this stock. | ||||||